Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...
HER2-positive refers to a characteristic found in certain cancer cells, where there’s an overexpression, or high level, of the HER2 protein. This protein is a receptor on the surface of cells.
And as trials testing Herceptin at earlier stages and in combination with other drugs continue, experts are starting to wonder what besides HER2 overexpression might be influencing an individual's ...
Too many copies of the HER2 gene or its overexpression appeared to cause an especially aggressive form of the disease. By the late ’90s, a drug called Herceptin that targeted the HER2 receptor, sped ...
Hosted on MSN2mon
Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer"From the excitement of identifying HER2 gene amplification and resultant protein overexpression as a targetable oncogene, through the development of drugs targeting HER2 amplification and ...
1 Human epidermal growth factor receptor 2 (HER2/ErbB2) overexpression, the most studied member of the type I receptor tyrosine kinase family, is present in up to 25% of women with breast cancer ...
By Kolade Adeyemo / Jambar Contributor Breast cancer is one of the most prevalent cancers worldwide, affecting millions of ...
As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the global CDK4/6 inhibitor market remains highly competitive ...
We are fully aware of the limitations of our study regarding the small number of patients included, but this report confirms previous findings on the overexpression of HER2 and blockade of HER2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results